| back to VEGF products | |
| This is a review about VEGF antibodies, based on 16 published articles using VEGF antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited VEGF antibody. Information in this review (with links to publications) can be searched freely. |
| list by method: blocking or activating expriments, ELISA, immunohistochemistry, immunoprecipitation, western blot |
SANTA CRUZ BIOTECHNOLOGY
Other Brands or Spellings: SANTA CRUZ, SANTA CRUZ BIOTECH, SANTA CRUZ BIOTECHNOLOGY INC., SANTA CRUZ BIOTECHNOLOGY INC, SANTZ CRUZ, SANTA CRUZ BIOTECHNOLOGIES |
|
In 2003, Tim D Eubank et al. used Santa Cruz anti-VEGF antibody in blocking or activating expriments to study the effect of M-CSF on VEGF production in human monocytes. In 2003, J Sato et al. used Santa Cruz Biotechnology monoclonal VEGF antibody in immunohistochemistry to study its expression in synovial tissues, and in 2005 Tomoyuki Okuda et al. used Santa Cruz Biotechnology rabbit anti-VEGF antibody (sc-152) in immunohistochemistry to study hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis. Santa Cruz Biotechnology anti-VEGF antibody was used in western blot in 2001 by I Huez et al. to study a new vascular endothelial growth factor isoform, in 2003 by Hiroki Kuniyasu et al. to study the production of interleukin 15 by human colon cancer cells associated with induction of mucosal hyperplasia, angiogenesis, and metastasis, in 2004 by Allen D Everett et al. to characterize hepatoma-derived growth factor, and in 2005 by Kip M Connor et al. to study the angiogenic phenotype regulation by mitochondrial H2O2 via PTEN oxidation and by Jinyi Shao et al. to study the transcriptional stimulation in colon cancer by prostaglandin E2.
|
R&D SYSTEMS
Other Brands or Spellings: R & D SYSTEMS, R&D, RNDSYSTEMS, R & D SYSTEM |
|
In 2005, Kip M Connor et al. used R & D Systems mouse anti-human IgG2B VEGF monoclonal neutralizing antibody to study the angiogenic phenotype regulation by mitochondrial H2O2 via PTEN oxidation.
R&D Systems anti-VEGF antibody was used in ELISA in 2003 by Eric S White et al. to study the expression of macrophage migration inhibitory factor and CXC chemokine in non-small cell lung cancer, and by Josiane Sanceau et al. to study the migratory-adhesive switch in Ewing's Sarcoma Cells triggered by matrix metalloproteinase-9 silencing, in 2005 by Raju R Raval et al. to study the differing effect of HIF1 and HIF2 in von Hippel-Lindau-Associated renal cell carcinoma and by Jinyi Shao et al. to study the transcriptional stimulation in colon cancer by prostaglandin E2, and in 2006 by Kenji Uchimura et al. to study the HSulf-2 which selectively mobilizes heparin-bound growth factors and chemokines.
In 2005, Arno Kuijper et al. used R&D Systems mouse monoclonal VEGF antibody in immunohistochemistry to study its expression in breast fibroepithelial tumors. In the same year, Ye Zhou et al. used R&D Systems anti-VEGF antibody in western blot to study the relationship between FPR expression and the biologic behavior of glioma cells.
|
LAB VISION
Other Brands or Spellings: LABVISION, NEOMARKERS, NEOMARKER, LAB VISION/NEOMARKERS |
| In 2006 Sylvia Major et al. tested Lab Vision VEGF Ab-3 antibody in western blot in the Abminer project.
|
UPSTATE BIOTECH
Other Brands or Spellings: CHEMICON, UPSTATE BIOTECHNOLOGIES, UPSTATE, UPSTATE BIOTECHNOLOGY, CHEMICON INTERNATIONAL, UPSTATE CELL SIGNALING, UPSTATE CELL SIGNALING SOLUTIONS, UPSTATE BIOTECHNOLOGY INC, UPSTATE LABORATORIES |
| In 2001, M K Tee et al. used Upstate Biotech human VEGF antibody in western blot to study a noval precursor form of vascular endothelial growth factor. |
Articles Reviewed | | 1. M K Tee et al. A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon. 2001 | | 2. I Huez et al. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. 2001 | | 3. Eric S White et al. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. 2003 | | 4. J Sato et al. Correlations of the expression of fibroblast growth factor-2, vascular endothelial growth factor, and their receptors with angiogenesis in synovial tissues from patients with internal derangement of the temporomandibular joint. 2003 | | 5. Josiane Sancéau et al. Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. 2003 | | 6. Tim D Eubank et al. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. 2003 | | 7. Hiroki Kuniyasu et al. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. 2003 | | 8. Allen D Everett et al. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. 2004 | | 9. Kip M Connor et al. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. 2005 | | 10. Tomoyuki Okuda et al. Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis. 2005 | | 11. Jinyi Shao et al. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. 2005 | | 12. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005 | | 13. Raju R Raval et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. 2005 | | 14. Arno Kuijper et al. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast. 2005 | | 15. Kenji Uchimura et al. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. 2006 | | 16. Sylvia Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
|